1-4 of 4
Yasuo Ohashi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Patient-Reported Outcome Results from the Open-Label Randomized Phase III SELECT BC Trial Evaluating First-Line S-1 Therapy for Metastatic Breast Cancer

Open Access
Subject Area:
Oncology
Takuya Kawahara, Kojiro Shimozuma, Takeru Shiroiwa, Yasuhiro Hagiwara, Yukari Uemura, Takanori Watanabe, Naruto Taira, Takashi Fukuda, Yasuo Ohashi, Hirofumi Mukai
Journal: Oncology
Oncology (2018) 94 (2): 107–115.
https://doi.org/10.1159/000484142
Published Online: 17 November 2017
View articletitled, Patient-Reported Outcome Results from the Open-Label Randomized Phase III SELECT BC Trial Evaluating First-Line S-1 Therapy for Metastatic Breast Cancer
Open the PDF for Patient-Reported Outcome Results from the Open-Label Randomized Phase III SELECT BC Trial Evaluating First-Line S-1 Therapy for Metastatic Breast Cancer in another window
Journal Articles

Subjective and Objective Assessment of Edema during Adjuvant Chemotherapy for Breast Cancer Using Taxane-Containing Regimens in a Randomized Controlled Trial: The National Surgical Adjuvant Study of Breast Cancer 02

Available to Purchase
Subject Area:
Oncology
Shozo Ohsumi, Kojiro Shimozuma, Yasuo Ohashi, Ayano Takeuchi, Kimito Suemasu, Masaru Kuranami, Shinji Ohno, Toru Watanabe
Journal: Oncology
Oncology (2012) 82 (3): 131–138.
https://doi.org/10.1159/000336480
Published Online: 15 March 2012
View articletitled, Subjective and Objective Assessment of Edema during Adjuvant Chemotherapy for Breast Cancer Using Taxane-Containing Regimens in a Randomized Controlled Trial: The National Surgical Adjuvant Study of Breast Cancer 02
Open the PDF for Subjective and Objective Assessment of Edema during Adjuvant Chemotherapy for Breast Cancer Using Taxane-Containing Regimens in a Randomized Controlled Trial: The National Surgical Adjuvant Study of Breast Cancer 02 in another window
Journal Articles

Irinotecan (CPT-11) and Cisplatin as First-Line Chemotherapy for Advanced Ovarian Cancer

Available to Purchase
Subject Area:
Oncology
Toru Sugiyama, Michiaki Yakushiji, Toshiharu Kamura, Masanori Ikeda, Naohiko Umesaki, Kazuo Hasegawa, Mutsuo Ishikawa, Fumitaka Saji, Masamichi Hiura, Takeshi Takahashi, Shinji Sato, Kazunori Ochiai, Fumitaka Kikkawa, Shoshichi Takeuchi, Yasuo Ohashi, Kiichiro Noda
Journal: Oncology
Oncology (2002) 63 (1): 16–22.
https://doi.org/10.1159/000065715
Published Online: 16 August 2002
View articletitled, Irinotecan (CPT-11) and Cisplatin as First-Line Chemotherapy for Advanced Ovarian Cancer
Open the PDF for Irinotecan (CPT-11) and Cisplatin as First-Line Chemotherapy for Advanced Ovarian Cancer in another window
Journal Articles

Phase II Study of Irinotecan and Cisplatin as First-Line Chemotherapy in Advanced or Recurrent Cervical Cancer

Available to Purchase
Subject Area:
Oncology
Toru Sugiyama, Michiaki Yakushiji, Kiichiro Noda, Masanori Ikeda, Ryouichi Kudoh, Akira Yajima, Yutaka Tomoda, Yoshiteru Terashima, Shoshichi Takeuchi, Masamichi Hiura, Fumitaka Saji, Takeshi Takahashi, Naohiko Umesaki, Shinji Sato, Masanori Hatae, Yasuo Ohashi
Journal: Oncology
Oncology (2000) 58 (1): 31–37.
https://doi.org/10.1159/000012076
Published Online: 14 January 2000
View articletitled, Phase II Study of Irinotecan and Cisplatin as First-Line Chemotherapy in Advanced or Recurrent Cervical Cancer
Open the PDF for Phase II Study of Irinotecan and Cisplatin as First-Line Chemotherapy in Advanced or Recurrent Cervical Cancer in another window